Literature DB >> 26049918

Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: results from a cross-sectional study.

Dominik G Haider1, Gregor Lindner2, Sufian S Ahmad2, Thomas Sauter2, Michael Wolzt3, Alexander Benedikt Leichtle4, Georg-Martin Fiedler4, Aristomenis K Exadaktylos2, Valentin Fuhrmann5.   

Abstract

BACKGROUND: Patients with electrolyte imbalances or disorders have a high risk of mortality. It is unknown if this finding from sodium or potassium disorders extends to alterations of magnesium levels. METHODS AND PATIENTS: In this cross-sectional analysis, all emergency room patients between 2010 and 2011 at the Inselspital Bern, Switzerland, were included. A multivariable logistic regression model was performed to assess the association between magnesium levels and in-hospital mortality up to 28days.
RESULTS: A total of 22,239 subjects were screened for the study. A total of 5339 patients had plasma magnesium concentrations measured at hospital admission and were included into the analysis. A total of 6.3% of the 352 patients with hypomagnesemia and 36.9% of the 151 patients with hypermagnesemia died. In a multivariate Cox regression model hypermagnesemia (HR 11.6, p<0.001) was a strong independent risk factor for mortality. In these patients diuretic therapy revealed to be protective (HR 0.5, p=0.007). Hypomagnesemia was not associated with mortality (p>0.05). Age was an independent risk factor for mortality (both p<0.001).
CONCLUSION: The study does demonstrate a possible association between hypermagnesemia measured upon admission in the emergency department, and early in-hospital mortality.
Copyright © 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critically ill; Emergency room; Hypermagnesemia; Hypomagnesemia; Mortality; Normomagnesemia

Mesh:

Substances:

Year:  2015        PMID: 26049918     DOI: 10.1016/j.ejim.2015.05.013

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  14 in total

1.  Deregulated renal magnesium transport during lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Manuel Meurer; Klaus Höcherl
Journal:  Pflugers Arch       Date:  2019-02-06       Impact factor: 3.657

2.  Abnormal magnesium levels and their impact on death and acute kidney injury in critically ill children.

Authors:  Hikaru Morooka; Akihito Tanaka; Daisuke Kasugai; Masayuki Ozaki; Atsushi Numaguchi; Shoichi Maruyama
Journal:  Pediatr Nephrol       Date:  2021-10-26       Impact factor: 3.714

3.  Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study.

Authors:  Heitor S Ribeiro; Emmanuel A Burdmann; Edilene A Vieira; Mateus L Ferreira; Aparecido P Ferreira; Antônio J Inda-Filho
Journal:  Clin Exp Nephrol       Date:  2022-06-27       Impact factor: 2.617

4.  Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.

Authors:  Huilin Tang; Xi Zhang; Jingjing Zhang; Yufeng Li; Liana C Del Gobbo; Suodi Zhai; Yiqing Song
Journal:  Diabetologia       Date:  2016-09-15       Impact factor: 10.122

5.  Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.

Authors:  Richard E Gilbert; Christian Mende; Ujjwala Vijapurkar; Sue Sha; Michael J Davies; Mehul Desai
Journal:  Diabetes Ther       Date:  2017-02-14       Impact factor: 2.945

6.  In vitro and in vivo responses of macrophages to magnesium-doped titanium.

Authors:  Bin Li; Huiliang Cao; Yaochao Zhao; Mengqi Cheng; Hui Qin; Tao Cheng; Yan Hu; Xianlong Zhang; Xuanyong Liu
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

Review 7.  Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.

Authors:  Juan R Muñoz-Castañeda; María V Pendón-Ruiz de Mier; Mariano Rodríguez; María E Rodríguez-Ortiz
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

8.  In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium.

Authors:  Paul Pagano; Andrea Marra; Dean Shinabarger; Chris Pillar
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

9.  Variations in Magnesium Concentration Are Associated with Increased Mortality: Study in an Unselected Population of Hospitalized Patients.

Authors:  Justyna Malinowska; Milena Małecka; Olga Ciepiela
Journal:  Nutrients       Date:  2020-06-19       Impact factor: 5.717

10.  The characteristics of patients with hypermagnesemia who underwent emergency hemodialysis.

Authors:  Mana Nishikawa; Noriaki Shimada; Motoko Kanzaki; Tetsunori Ikegami; Toshio Fukuoka; Masaki Fukushima; Kenichiro Asano
Journal:  Acute Med Surg       Date:  2018-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.